Sweden· SE-20040310000011
Faslodex 250 mg Injektionsvätska, lösning i förfylld spruta
A medicinal product containing fulvestrant, registered in Sweden by AstraZeneca AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Fulvestrant
- Manufacturer
- AstraZeneca AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20040310000011
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fulvestrant in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFASLODEXAstraZeneca AB, Södertälje
- SpainAFULTRANT 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFGBexal Farmaceutica S.A.
- BelgiumFaslodex 250 mgAstraZeneca
- PolandFulvestrant CiplaCipla Europe NV
- IcelandFulvestrant AccordAccord Healthcare B.V.
- NorwayFulvestrant AccordAccord Healthcare B.V.
- IrelandFaslodex 250 mg Solution for injectionAstraZeneca AB
- United StatesCLIGAVYXAvyxa Pharma, LLC
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Fulvestrant +pharma, Fulvestrant Accord
- Belgium · Fulvestrant Accord, Fulvestrant Eugia
- Bulgaria · Fulvestrant Ever Pharma, Fulvestrant Pharmascience
- Cyprus · Fulvestrant Accord, Fulvestrant Rompharm
- Czechia · Fulvestrant Accord, Fulvestrant Ever Pharma
- Germany · Fulvestrant 1 A Pharma, Fulvestrant Abz
- Denmark · Fulvestrant "stada", Fulvestrant Accord
- Estonia · Fulvestrant Accord, Fulvestrant Aliud
- Spain · Afultrant, Ambiful
- Finland · Fulvestrant Accord, Fulvestrant Ever Pharma
- France · Fulvestrant, Fulvestrant Accord
- United Kingdom (Northern Ireland) · Fulvestrant Accord Healthcare, Fulvestrant Dr. Reddy's
- Greece · Fulvestrant Accord, Fulvestrant Demo
- Croatia · Fulvestrant Accord, Fulvestrant Aptapharma
- Hungary · Fulvestrant Aptapharma, Fulvestrant Elc
- Ireland · Fulvestrant Accord Healthcare Ireland, Fulvestrant Ever Pharma
- Iceland · Faslodex, Fulvestrant Accord
- Italy · Fulvestrant Accord, Fulvestrant Aurobindo
- Liechtenstein · Faslodex, Fulvestrant Mylan
- Lithuania · Fulvestrant Aliud, Fulvestrant Orion
- Luxembourg · Fulvestrant Teva
- Latvia · Fulvestrant Aliud, Fulvestrant Stada
- Malta · Fulvestrant Ever Pharma
- Netherlands · Fulvestrant, Fulvestrant Accord
- Norway · Faslodex, Fulvestrant Accord
- Poland · Fulvestrant Eugia, Fulvestrant Ever Pharma
- Portugal · Ambiful, Cykostra
- Romania · Falvax, Fulvestrant Accord
- Slovenia · Fulvestrant Accord, Fulvestrant Aptapharma
- Slovakia · Fulvestrant Accord, Fulvestrant Ever Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3d69591-9982-4130-8f32-43239e4db3bc GET /v1/drugs/d3d69591-9982-4130-8f32-43239e4db3bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20040310000011",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20040310000011",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/faslodex-epar-product-information_sv.pdf"
}See everything about fulvestrant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.